PE20080329A1 - Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol - Google Patents

Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol

Info

Publication number
PE20080329A1
PE20080329A1 PE2007000682A PE2007000682A PE20080329A1 PE 20080329 A1 PE20080329 A1 PE 20080329A1 PE 2007000682 A PE2007000682 A PE 2007000682A PE 2007000682 A PE2007000682 A PE 2007000682A PE 20080329 A1 PE20080329 A1 PE 20080329A1
Authority
PE
Peru
Prior art keywords
aerosol
treatment
drug
dextrose
inhalers
Prior art date
Application number
PE2007000682A
Other languages
English (en)
Inventor
Hanumantharao Tatapudy
M Shah Syed
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20080329A1 publication Critical patent/PE20080329A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE UN ANTIBIOTICO SELECCIONADO DE ZOSYN, PIPERACILINA, TAZOBACTAM O TYGACIL; Y UN DILUYENTE SELECCIONADO DE AGUA ESTERIL PARA INYECTABLE, 0.9% DE CLORURO DE SODIO, 5% DE DEXTROSA, 5% DE DEXTROSA EN SOLUCION RINGER LACTADA PARA INYECCION. DICHA COMPOSICION ES UN AEROSOL, DONDE EL SUMINISTRO DE DROGA, CUYO TAMANO DE PARTICULA ES DE 1-3 MICRONES EN AEROSOL, COMPRENDE UN INHALADOR DE POLVO SECO EN DOSIS UNITARIA, UN DISPOSITIVO PULMONAR PARA POLVO SECO, INHALADORES PRESURIZADOS PARA DOSIS MEDIDAS O UN NEBULIZADOR, ENTRE OTRAS. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE TRASTORNOS RESPIRATORIOS PROVOCADOS POR LA FIBROSIS CISTICA
PE2007000682A 2006-06-07 2007-06-01 Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol PE20080329A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167206P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
PE20080329A1 true PE20080329A1 (es) 2008-04-09

Family

ID=38508902

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000682A PE20080329A1 (es) 2006-06-07 2007-06-01 Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol

Country Status (4)

Country Link
AR (1) AR061262A1 (es)
PE (1) PE20080329A1 (es)
TW (1) TW200815002A (es)
WO (1) WO2007145868A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (zh) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 一种替加环素组合物的制备方法
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2020239696A1 (en) * 2019-05-24 2020-12-03 Stichting Katholieke Universiteit Improved administration of glycylcyclines by inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5611332A (en) * 1995-03-22 1997-03-18 Bono; Michael Aerosol inhalation device containing a rain-off chamber
GB0004531D0 (en) * 2000-02-25 2000-04-19 Richards Andrew J M The treatment of respiratory diseases
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
AU2003225689B2 (en) * 2002-03-05 2009-03-26 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex

Also Published As

Publication number Publication date
WO2007145868A1 (en) 2007-12-21
AR061262A1 (es) 2008-08-13
TW200815002A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
PE20080329A1 (es) Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol
ES2644572T3 (es) Un inhalador que comprende una composición que contiene tiotropio
ES2809565T3 (es) Dispositivo de administración de aerosol
CL2007001018A1 (es) Inhalador para administrar un medicamento en forma de sustancias inhalables, formulaciones o mezclas de sustancias, comprende una carcasa que presenta un interior para lojar el medicamento, la carcasa esta unida de forma fija a una boquilla, ademas puede incorporar una aguja para perforar una capsula con medicamento.
ES2552506T3 (es) Aparato de atomización nasal
AR080444A1 (es) Metodos para la utilizacion de cotransportadores de sodio-glucosa 1 y 2
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
AR066074A1 (es) Dispositivo de inyeccion para dispensar un medicamento
JP2009269923A5 (es)
RS51107B (sr) Mehanizam za prikazivanje odabrane doze medikamenta za primenu kod uređaja za unošenje medikamenata u telo pacijenta
ES2895875T3 (es) Dispositivo de administración de aerosol y método de funcionamiento para el dispositivo de administración de aerosol
BRPI0707235B8 (pt) formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
GB2440039A (en) Devices, systems and methods for medicament delivery
BRPI0508170A (pt) formulações farmacêuticas para inaladores de pó seco, que compreendem um ingrediente ativo de potência de baixa dosagem
AR095547A1 (es) Nebulizador para bebes y pacientes con compromiso respiratorio
PE20080712A1 (es) Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador
JP2015523395A5 (es)
CO5690570A2 (es) Nueva combinacion sinergistica que comprende roflumilast y formoterol
CO6140021A2 (es) Composicion farmaceutica de liberacion modificada de un musculo relajante y un aine
AR099364A1 (es) Inhalador de medicamentos
Stockmann et al. Clinical pharmacokinetics of inhaled antimicrobials
US20210352905A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
Rossi et al. Resistant tuberculosis: the latest advancements of second-line antibiotic inhalation products
CO6270213A2 (es) Composiciones farmaceuticas que comprenden acido montelukast y un unhibidor depde-4 o un corticoesteroide inhalado para administracion por inhalacion
ES2526560T3 (es) Teobromina para el tratamiento de la tos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal